Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-065844

Chief Scientific Officer sold 1,319 shares at an average $64.81 ($85,483)

  • Chief Scientific Officer acquired 4,445 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Garfield Alastair Chief Scientific Officer 2025-07-01 Option exercise 10b5-1 +4,445 4,445 D
Garfield Alastair Chief Scientific Officer 2025-07-02 Sale 10b5-1 −1,313 $64.81 $85,096 3,132 D
Garfield Alastair Chief Scientific Officer 2025-07-02 Sale 10b5-1 −6 $64.60 $388 3,126 D
Derivatives
Garfield Alastair Chief Scientific Officer 2025-07-01 Option exercise · Restricted Stock Units 10b5-1 −4,445 13,333 D
Open-market sales · 1,319 sh · avg $64.81 · $85,483
Loading xslF345X05/tm2519881-1_4seq1.xml…